中国组织工程研究与临床康复
中國組織工程研究與臨床康複
중국조직공정연구여림상강복
JOURNAL OF CLINICAL REHABILITATIVE TISSUE ENGINEERING RESEARCH
2010年
10期
1769-1774
,共6页
林楠%谢树杰%潘卫东%胡昆鹏%陈思%崇雨田%项鹏%许瑞云
林楠%謝樹傑%潘衛東%鬍昆鵬%陳思%崇雨田%項鵬%許瑞雲
림남%사수걸%반위동%호곤붕%진사%숭우전%항붕%허서운
肝纤维化%干细胞%细胞移植%肝星状细胞%细胞凋亡
肝纖維化%榦細胞%細胞移植%肝星狀細胞%細胞凋亡
간섬유화%간세포%세포이식%간성상세포%세포조망
背景:骨髓间质干细胞治疗肝纤维化的疗效己得到很多实验的证实,但其机制仍不明确.目的:实验观察骨髓间质干细胞移植后肝星状细胞的凋亡情况,初步探讨骨髓间质干细胞治疗肝纤维化的机制.方法:连续8周皮下注射CCl_4诱导大鼠肝纤维化.造模成功后,20只大鼠随机分为实验组及对照组,每组10只.实验组经尾静脉注射骨髓间充质干细胞,对照组经尾静脉注射DMEM培养液.于移植前,移植后第3,7天分别处死大鼠,取其肝脏行羟脯氨酸的检测,苏木精-伊红染色及masson染色,免疫组织化学检测α-SMA及α-SMA+TUNEL双染反映肝星状细胞活化及其凋亡情况.结果与结论:造模8周后,大鼠肝脏羟脯氨酸含最明显升高,病理呈进展性肝纤维化表现.移植7 d后,实验组大鼠肝脏羟脯氨酸含量明显降低,肝纤维化有所缓解,而对照组的肝纤维化程度继续加重.免疫组织化学显示,CCl_4注射8周后,α-SMA阳性细胞大量增生,移植后第7天,实验组α-SMA阳件细胞明显少于对照组(P<0.05).移植后第3天,实验组肝星状细胞凋亡明显较对照组增加(P<0.05).结果提示,骨髓间质干细胞移植有治疗肝纤维化的作用.骨髓间质干细胞诱导肝星状细胞凋亡可能是其治疗肝纤维化的主要机制之一.
揹景:骨髓間質榦細胞治療肝纖維化的療效己得到很多實驗的證實,但其機製仍不明確.目的:實驗觀察骨髓間質榦細胞移植後肝星狀細胞的凋亡情況,初步探討骨髓間質榦細胞治療肝纖維化的機製.方法:連續8週皮下註射CCl_4誘導大鼠肝纖維化.造模成功後,20隻大鼠隨機分為實驗組及對照組,每組10隻.實驗組經尾靜脈註射骨髓間充質榦細胞,對照組經尾靜脈註射DMEM培養液.于移植前,移植後第3,7天分彆處死大鼠,取其肝髒行羥脯氨痠的檢測,囌木精-伊紅染色及masson染色,免疫組織化學檢測α-SMA及α-SMA+TUNEL雙染反映肝星狀細胞活化及其凋亡情況.結果與結論:造模8週後,大鼠肝髒羥脯氨痠含最明顯升高,病理呈進展性肝纖維化錶現.移植7 d後,實驗組大鼠肝髒羥脯氨痠含量明顯降低,肝纖維化有所緩解,而對照組的肝纖維化程度繼續加重.免疫組織化學顯示,CCl_4註射8週後,α-SMA暘性細胞大量增生,移植後第7天,實驗組α-SMA暘件細胞明顯少于對照組(P<0.05).移植後第3天,實驗組肝星狀細胞凋亡明顯較對照組增加(P<0.05).結果提示,骨髓間質榦細胞移植有治療肝纖維化的作用.骨髓間質榦細胞誘導肝星狀細胞凋亡可能是其治療肝纖維化的主要機製之一.
배경:골수간질간세포치료간섬유화적료효기득도흔다실험적증실,단기궤제잉불명학.목적:실험관찰골수간질간세포이식후간성상세포적조망정황,초보탐토골수간질간세포치료간섬유화적궤제.방법:련속8주피하주사CCl_4유도대서간섬유화.조모성공후,20지대서수궤분위실험조급대조조,매조10지.실험조경미정맥주사골수간충질간세포,대조조경미정맥주사DMEM배양액.우이식전,이식후제3,7천분별처사대서,취기간장행간포안산적검측,소목정-이홍염색급masson염색,면역조직화학검측α-SMA급α-SMA+TUNEL쌍염반영간성상세포활화급기조망정황.결과여결론:조모8주후,대서간장간포안산함최명현승고,병리정진전성간섬유화표현.이식7 d후,실험조대서간장간포안산함량명현강저,간섬유화유소완해,이대조조적간섬유화정도계속가중.면역조직화학현시,CCl_4주사8주후,α-SMA양성세포대량증생,이식후제7천,실험조α-SMA양건세포명현소우대조조(P<0.05).이식후제3천,실험조간성상세포조망명현교대조조증가(P<0.05).결과제시,골수간질간세포이식유치료간섬유화적작용.골수간질간세포유도간성상세포조망가능시기치료간섬유화적주요궤제지일.
BACKGROUND:It is reported that bone marrow mesenchymal stem cell(BMSC)transplantation might be a promising treatment for liver fibrosis.But the mechanism is still unclear.OBJECTIVE:To observe the hepatic stellate cells apoptosis induced by BMSC transplantation,and to study the mechanism of BMSC in treating hepatic fibrosis in vivo.METHODS:CCl_4 subcutaneous injection was performed to induce rat liver fibrosis.After 8 weeks of CCU injection,20 rats which underwent successful model establishment were randomly divided into experimental group and control group,10 in each group.The experimental group received MSC transplantation via tail vein injection,and the control group were given DMEM instead.The rats were killed and the livers were harvested at three time point,the day of MSC transplantation,3 days after transplantation,and 7 days after transplantation.The hydroxyproline content was detected by HE and Masson staining,and the expression changes of α-smooth muscle actin(α-SMA)proteins were determined using immunohistochemistry.The apoptosis of hepatic stellate cells were determined by α-SMA and TUNEL(terminal dUTP nick-end labeling)dual-staining.RESULTS AND CONCLUSION:After 8 weeks of CCU injection,the hydroxyproline content increased and histology indicated progress of liver fibrosis.At 7 days after MSC transplantation,the hydroxyproline in the liver was decreased,and the liver fibrosis was alleviated in the experimental group but aggravated in the control group.Immunohistochemistry indicated that α-SMA positive cells were increased at 8 weeks after CCU injection.At day 7 after transplantation,α-SMA positive cells in the experimental group were significantly less than control group(P < 0.05).At 3 days after transplantation,the hepatic stellate cells apoptosis in the experimental group was significantly aggravated compared with control group(P < 0.05).This suggested that MSC transplant was an effective treatment for liver fibrosis.MSC inducing hepatic stellate cells apoptosis may be one of the mechanisms.